Ann: Ceasing to be a substantial holder from Arix Bioscience, page-44

First 44 Last

Share
Profile

Follow
ChipLeigh

1,625 Posts.

301

06/11/20

22:16

Post #: 48700692
Share

Originally posted by burner_7: ↑

Not sure if this has been posted but does explain why Arix bio. sold their whole holding.

As per their September results preso (refer page 18-19 of attached) they pre planned to reduce from a 16 company portfolio to 11 and as a result they had to sell out of 5 companies and pharmaxis was indeed one preempted for the chopping block. The only way to do so for a small co. Like pxs is to do it on a high liquidity day like the Fed announcement.

It's fair to worry and good to understand the logic behind the selling of substantial holders, especially in this case due to it being on good news and being 100% of their holdings. But you'll find that their holding in pxs would be immaterial for them due to it being less that 2% of the total fum so the volume would probably be more important than the exit price.

That all said I believe anyone purchasing shares 10c or below will be cheering Arix had to sell off as there'd be no way you'd be getting such a low entry otherwise. An enterprise value of $4mill for a reasonably mature pharma with the talent, pipeline and cashflow of pxs seems ridiculously cheap and doesn't come around too often from my experience.

Anyway just my findings and opinion.. good luck!

Expand

That's why I bought in today under 10c... I am certain today was traders letting go of positions due to bigger sellers...

PXS Price at posting: 9.9¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

MKT

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

ION

Iondrive battery recovery achieves strong critical minerals recovery from black mass

CXO

Core Lithium jumps 10% on gold assay hits; drill run expansion

HRE

Deal between Heavy Rare Earths, Havilah hands former SA uranium assets

M2M

M2M pours gold bar, finds 458.39g/t assay through bulk sampling at Golden Crown

There are more pages in this discussion • 29 more messages in this thread...

First 44 Last

Add SNT (ASX) to my watchlist

(20min delay)
Last 5.5¢		Change 0.003(5.77%)		Mkt cap ! $76.89M

Open	High	Low	Value	Volume
5.5¢	5.8¢	5.4¢	$160.9K	2.883M

Buyers (Bids)

No.	Vol.	Price($)
4	43930	5.5¢

Sellers (Offers)

Price($)	Vol.	No.
5.6¢	105945	3

View Market Depth

No.	Vol.	Price($)
4	43930	0.055
4	316228	0.054
2	67746	0.053
3	221152	0.052
4	357584	0.051

Price($)	Vol.	No.
0.056	125818	4
0.057	261415	3
0.058	194700	4
0.059	416966	2
0.060	659667	5

Last trade - 11.56am 21/10/2024 (20 minute delay)

SNT (ASX) Chart

Ann: Ceasing to be a substantial holder from Arix Bioscience, page-44

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Iondrive battery recovery achieves strong critical minerals recovery from black mass

Core Lithium jumps 10% on gold assay hits; drill run expansion

Deal between Heavy Rare Earths, Havilah hands former SA uranium assets

M2M pours gold bar, finds 458.39g/t assay through bulk sampling at Golden Crown

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Ceasing to be a substantial holder from Arix Bioscience, page-44

Top Stories

The ASX can overlook its Telecomm small-caps. Here’s one diversified brand with an international footprint

Iondrive battery recovery achieves strong critical minerals recovery from black mass

Core Lithium jumps 10% on gold assay hits; drill run expansion

Deal between Heavy Rare Earths, Havilah hands former SA uranium assets

M2M pours gold bar, finds 458.39g/t assay through bulk sampling at Golden Crown

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News